logo
Living at Mar-a-Lago puts Trump at risk for this major health issue, according to a new study

Living at Mar-a-Lago puts Trump at risk for this major health issue, according to a new study

New York Post15-05-2025

President Trump's most recent annual physical revealed he's in 'excellent health,' going so far as to point to his 'frequent victories in golf events' as evidence.
But a new study published in JAMA Network Open suggests his love of the game and residence at Mar-a-Lago may be putting him at risk of an unexpected health condition.
3 President Trump's recent annual physical revealed he's in 'excellent health,' noting his 'frequent victories in golf events.'
AFP via Getty Images
Advertisement
Living within a mile of a golf course carries a whopping 126% higher risk of developing Parkinson's disease versus living more than 6 miles away, according to data from over 5,500 people.
The risk decreased with distance but remained elevated up to 3 miles away.
Advertisement
Researchers attribute this increased risk to potential exposure to pesticides used in golf course maintenance.
These chemicals can leach into groundwater or become airborne, exposing nearby residents.
The risk was notably higher for individuals relying on groundwater sources for drinking water, especially in areas where the groundwater is more susceptible to contamination.
Mar-a-Lago — Trump's private club and residence in Palm Beach, Florida — features a golf course and is situated in a region with a high water table, potentially increasing vulnerability to groundwater contamination.
Advertisement
3 Mar-a-Lago — Trump's private club and residence in Palm Beach, Florida — features a golf course and is situated in a region with a high water table.
Getty Images
It's important to note that the study suggests an association, not causation, between proximity to golf courses and increased Parkinson's risk — but the findings align with previous research on pesticides.
'Many studies have investigated whether pesticides increase the risk of developing Parkinson's in different populations around the world,' Katherine Fletcher, lead researcher at Parkinson's UK, said in a statement.
'The results have been varied, but overall suggest that exposure to pesticides may increase the risk of the condition. However, the evidence is not strong enough to show that pesticide exposure directly causes Parkinson's.'
Advertisement
3 Around 1.1 million people in the US are estimated to have Parkinson's disease.
highwaystarz – stock.adobe.com
Around 1.1 million Americans are estimated to have Parkinson's.
While there is no cure for the neurodegenerative disorder, treatment options are evolving.
A recent study suggested psilocybin — the psychedelic compound that gave 'magic mushrooms' their trippy reputation in the 1960s — is showing serious promise for improving mood and motor function in people with Parkinson's.
Tavapadon — a new drug that mimics dopamine by targeting certain receptors in the brain — has demonstrated potential in clinical trials by reducing motor fluctuations and maintaining symptom control with fewer side effects than traditional therapies.
And Produodopa — a continuous infusion therapy first administered in the UK — was approved by the US Food and Drug Administration last fall.
Advertisement
Experts recommend lowering your risk of developing Parkinson's by exercising and eating a healthy diet.
That may mean giving up fast food — fore-ever.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Mushroom Recall Sparks Nationwide Warning to Customers
Mushroom Recall Sparks Nationwide Warning to Customers

Newsweek

time33 minutes ago

  • Newsweek

Mushroom Recall Sparks Nationwide Warning to Customers

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. Hofood99 Inc. is recalling packages of their Enoki Mushrooms due to fears the product may be contaminated with listeria. Newsweek reached out to the company via phone for additional comment on Wednesday and left a voicemail. Why It Matters Numerous recalls have been initiated this year due to the potential for the following: damaged products, foodborne illness, contamination and undeclared food allergens. Millions of Americans experience food sensitivities or food allergies every year. According to the Food and Drug Administration (FDA), the nine "major" food allergens in the U.S. are eggs, milk, fish, wheat, soybeans, Crustacean shellfish, sesame, tree nuts and peanuts. The FDA warns that Listeria monocytogenes is an organism that could cause serious and sometimes fatal infections in frail or older people, young children and those with weakened immune systems. Listeria could also lead to stillbirths or miscarriages in pregnant women, the FDA says. What To Know According to the FDA alert, the mushrooms were distributed nationwide to stores and retailers. The recalled mushrooms are sold in 200-gram green plastic packaging with a with UPC Barcode of 6 976532 310051 seen on the back label. No illnesses or injuries have been reported related to the recalled mushrooms. The mushrooms were distributed by Hofood99 Inc., located at 21903 56th Avenue Oakland Gardens, New York 11364. Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) Recalled packages of Enoki Mushroom from Hofood99 Inc. can be seen in a June 11, 2025, recall alert. (Photo from the U.S. Food and Drug Administration) What People Are Saying The FDA in the alert in part: "The contamination was discovered after samples were collected from a store in Michigan and subsequent analysis by Michigan Department of Agriculture & Rural Development (MDARD) Laboratory Division revealed the presence of Listeria monocytogenes." In an email to Newsweek in January, the FDA said: "Most recalls in the U.S. are carried out voluntarily by the product manufacturer and when a company issues a public warning, typically via news release, to inform the public of a voluntary product recall, the FDA shares that release on our website as a public service. "The FDA's role during a voluntary, firm-initiated, recall is to review the recall strategy, evaluate the health hazard presented by the product, monitor the recall, and as appropriate alert the public and other companies in the supply chain about the recall," the FDA continued. It added: "The FDA provides public access to information on recalls by posting a listing of recalls according to their classification in the FDA Enforcement Report, including the specific action taken by the recalling company. The FDA Enforcement Report is designed to provide a public listing of products in the marketplace that are being recalled." Additional information on recalls can be found via the FDA's Recalls, Market Withdrawals, & Safety Alerts. What Happens Next Customers who have purchased the recalled mushrooms may return the product to the original place of purchase for a full refund or destroy it, the FDA says. People with additional questions may contact the company at (917) 756-9833 weekdays from 9 a.m. to 2 p.m.

Church hosts conference to address mental health in the Black community
Church hosts conference to address mental health in the Black community

Yahoo

timean hour ago

  • Yahoo

Church hosts conference to address mental health in the Black community

MEMPHIS, Tenn. — According to the Centers for Disease Control (CDC), in 2023, suicide was the third leading cause of death among African Americans ages 15 to 34 in the U.S. Pastor Dianne Young with the Healing Center says this is why her church gathered professionals from across the country to educate people about depression and break the silence surrounding suicide in the Black community. 'We want to be able to let people talk freely about their struggles. We mention that we have them, but we don't talk about it,' said Pastor Young. Her church hosted the National Suicide and Black Church Conference at Southwest Community College. 📡 for Memphis and the Mid-South. 📧 and have the latest top stories sent right to your inbox. 'There was a theory that it didn't happen to Black people or African-Americans, but we found out it did from our own personal experiences,' she said. Executive Director of the American Psychiatric Association Foundation, Rawle Andrews Jr., says the stigma surrounding depression among Black people stems from three things: fear, shame, and discrimination. 'We were already thought to be less than human or second class, and then when I tell you I'm struggling with a mental health condition, now I'm leaning into the perception that I'm less than. I'm less than human,' said Andrews Jr. The APA says some of the common warning signs include talking or writing about death, withdrawal from friends and family, dramatic mood changes, and increased alcohol or drug use. 'If you don't see that person for a couple of days and their body language changes, get interested. Get curious,' said a workshop speaker. 'This is teaching you all to recognize, not diagnose, because when you diagnose somebody inappropriately, that can feel like a judgment or a label. Don't do that.' If you or someone you know is experiencing a crisis, experts encourage you to call the National Suicide and Crisis Lifeline at 988. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Jim Cramer on Cardinal Health: 'I am a Believer'
Jim Cramer on Cardinal Health: 'I am a Believer'

Yahoo

timean hour ago

  • Yahoo

Jim Cramer on Cardinal Health: 'I am a Believer'

Cardinal Health, Inc. (NYSE:CAH) is one of the 11 stocks on Jim Cramer's radar. Calling Cardinal Health, Inc.'s (NYSE:CAH) upcoming Investor Day a possible needle mover, Cramer said: 'Now, Thursday brings some analyst meetings that could move the needle. Cardinal Health, we've had them on a couple of times, tells a terrific story about how it's much more than a drug middleman. And I believe, I am a believer.' A senior physician in a modern healthcare institution administering medication to a patient. Cardinal Health (NYSE:CAH) provides medical products and services used in various care settings. The company delivers pharmaceuticals, equipment, and support tools while managing distribution, logistics, and pharmacy operations through healthcare-focused technology. On May 14, Cramer extensively commented on the company as he said: 'These stocks, namely Cardinal Health, Cencora, and McKesson, are seemingly perpetual residents on the new high list. Over the long haul, they're some of the best performers out there, and they've done great this year, as is pretty much always the case. And yet, doesn't it always feel like the drug distributors are just one bad day away from falling apart… Let's not forget that the drug distributors are making fortunes right now. Cardinal Health turned in an excellent set of numbers two weeks ago with double-digit earnings growth. Management put through a big boost in their full-year earnings forecast. Cardinal stock jumped 3% in response, climbing from $141 to $145, and it kept running for really a week after that, eventually setting at an all-time high of $154 just last Thursday. What a fabulous move… While we acknowledge the potential of CAH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store